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Background: In the oncology setting, there has been increasing interest in evaluating treatment outcomes in
terms of quality of life and patient satisfaction. The aim of our study was to investigate the determinants of patient
satisfaction, especially the relationship between quality of life and satisfaction with care and their changes over
time, in curative treatment of cancer outpatients.
Methods: Patients undergoing ambulatory chemotherapy or radiotherapy in two centers in France were invited
to complete the OUT-PATSAT35, at the beginning of treatment, at the end of treatment, and three months after
treatment. This questionnaire evaluates patients’ perception of doctors and nurses, as well as other aspects of
care organization and services. Additionally, for each patient, socio-demographic and clinical characteristics, and
self-reported quality of life data (EORTC QLQ-C30) were collected.
Results: Of the 691 patients initially included, 561 answered the assessment at all three time points. By
cross-sectional analysis, at the end of the treatment, patients who experienced a deterioration of their global health
reported less satisfaction on most scales (p ≤ 0.001). Three months after treatment, the same patients had lower
satisfaction scores only in the evaluation of doctors (p ≤ 0.002). Furthermore, longitudinal analysis showed a
significant relationship between a deterioration in global health and a decrease in satisfaction with their doctor
and, conversely, between an improvement in global health and an increase in satisfaction on the overall satisfaction
scale. Global health at baseline was largely and significantly associated with all satisfaction scores measured at the
following assessment time points (p < 0.0001). Younger age (<55 years), radiotherapy (versus chemotherapy) and
head and neck cancer (versus other localizations) were clinical factors significantly associated with less satisfaction
on most scales evaluating doctors.
Conclusions: Pre-treatment self-evaluated global health was found to be the major determinant of patient
satisfaction with care. The subsequent deterioration of global health, during and after treatment, emphasized the
decrease in satisfaction scores, mainly in the evaluation of doctors. Early initiatives aimed at improving the delivery
of care in patients with poor health status should lead to improved perception of the quality of care received.
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In the last few decades, patient satisfaction has become
an important endpoint in the assessment of the quality
of care, which is increasingly required by accreditation
agencies in monitoring of quality of hospital care. More-
over, satisfaction with care may influence patient compli-
ance to treatment and consequently, impact on disease
outcome.
In the setting of oncology, advances in diagnostics,
treatment, supportive care and rehabilitation call for
regular evaluations, in order to determine whether pa-
tients’ expectations are being met by the complex and
multidisciplinary nature of the healthcare that they re-
ceive. Thus, patient satisfaction surveys can help to
identify patient groups who merit additional attention
or even targeted interventions, and can also highlight
areas of the care process where there is room for im-
provement. Several studies have focused on patient
satisfaction in specific cancer treatments, such as
gastro-esophageal [1], breast [2,3], colorectal [4], and
gynaecological cancers [5]. However, few included a
large sample size and a heterogeneous population as
regards cancer types [6-8]. Similarly, a number of stud-
ies have been conducted to evaluate the predictors of
patient satisfaction in various oncology care settings,
and more recently in the context of ambulatory treat-
ment [9-12]. Socio-demographic characteristics (age,
sex, education level, marital status) and health status
are the most widely studied predictors of satisfaction
[7,8,13-15], but conflicting results have been reported,
especially regarding the relationship between self-
perceived quality of life (QoL) and satisfaction with
care [16-20]. However, to the best of our knowledge,
no study has yet evaluated the effect of longitudinal
changes in a patient’s QoL on their satisfaction with
care over time.
In a previous cross-sectional study of French cancer
outpatients evaluated at the beginning of their ambula-
tory chemo- or radiotherapy, we identified a number of
clinical factors (primary cancer, type of treatment re-
ceived) and socio-demographic factors (marital status,
age) that were significantly associated with different do-
mains of satisfaction with care. Nevertheless, the major
determinant was the patient’s global health status, sug-
gesting that self-reported QoL is a key element in under-
standing cancer patient satisfaction [21].
The goal of the present study was, firstly, to ascertain
the influence of clinical and socio-demographic factors
previously identified as potential determinants of satis-
faction with care, at several assessment time points dur-
ing and after treatment. Secondarily, we investigated the
influence of longitudinal changes in self-reported QoL
on variations in satisfaction with care, as measured by
multi-dimensional questionnaires.Methods
We conducted a multicenter, prospective cohort study
of cancer outpatients from the beginning of treatment
and until three months after the end of treatment.
The protocol was approved by the regional ethics
committee of the University Hospital of Besançon for
both participating hospitals (Comité de Protection des
Personnes Est-II, France), the National French Data
Protection Agency, and was supported by a regional grant
from the French National Hospital Research Programme
(Programme Hospitalier de Recherche Clinique, PHRC).
All patients provided written informed consent.
Patients
Patients were enrolled in two centers (one university
teaching hospital and one non-academic hospital) in
eastern France between January 2005 and December
2006. Inclusion criteria were: patients aged over 18
years, able to understand written and spoken French,
able to provide written consent, able to complete the
questionnaires, with a confirmed histological diagnosis
of cancer, and due to undergo ambulatory treatment by
chemo- or radiotherapy.
The following cancers were included in 9 treatment
groups: 2 prostate cancer groups (radiotherapy only or
surgery followed by radiotherapy), 3 breast cancer groups
(surgery plus radiotherapy, or surgery plus chemo and
radiotherapy, or chemotherapy alone), 2 head and neck
cancer groups (surgery plus radiotherapy or radiotherapy
with or without concurrent chemotherapy), 1 rectum can-
cer group (radiochemotherapy plus surgery) and 1 lung
cancer group (chemo and radiotherapy).
Study procedures and measures
As described previously [21], patients were orally invited
to participate in the study by the research technician
when they came to the hospital at the beginning of the
first week of radiotherapy or at the first cycle of chemo-
therapy. However, it was not technically possible to meet
all patients on a systematic basis. Once the patient
agreed to participate and provided informed consent,
the socio-demographic questionnaire was completed
with the research technician. Patients were asked to
complete the EORTC QLQ-C30 and OUT-PATSAT35
questionnaires at three different time points: i.e. at the
beginning of treatment (at the end of the first week of
radiotherapy or at the second cycle of chemotherapy), at
the end of treatment (at the last week of radiotherapy or
at the sixth cycle of chemotherapy) and three months
after the end of treatment. Only one treatment group,
namely breast cancer patients who underwent surgery
plus chemotherapy and radiotherapy, had to complete
the questionnaires at four different time points because
we assessed their satisfaction with care both at the end
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questionnaire for the first time point was completed at
the hospital. For the two subsequent time points (end of
treatment and three months after treatment), question-
naires were given to the patient during treatment visits
or consultations, and were completed at home and
mailed back using a stamped addressed envelope. If ne-
cessary, patients were called by phone and reminded to
return the questionnaires two weeks later.
The EORTC IN-PATSAT32 questionnaire was devel-
oped by the EORTC QOL group in order to assess pa-
tient satisfaction with care in oncology hospitals [22].
The OUT-PATSAT35 questionnaire was adapted from
IN-PATSAT32 for use among outpatients treated by am-
bulatory chemotherapy or radiotherapy. Adequate psy-
chometric properties have been reported for the French
and Spanish language versions [23-25].
The OUT-PATSAT35 questionnaires contains 35
items covering 12 multi-item scales organized into three
sections of four scales each: two sections evaluating doc-
tors and nurses (for chemotherapy) or radiation thera-
pists (for radiotherapy), as regards their technical skills
(knowledge, experience, assessment of physical symp-
toms), interpersonal skills (interest, willingness to listen),
provision of information (about the disease, medical
tests and treatment), and availability (time devoted to
patients). The third section evaluates the organization of
the department, the exchange of information between
caregivers (coherence, identification of the reference
doctor), the interpersonal skills and quality of informa-
tion provided by other hospital staff, waiting times (for
consultation, medical tests, or treatment), the physical
environment (access, comfort, orientation), and lastly, a
single-item : the overall satisfaction scale.
Items are rated on a 5-level Likert scale as follows:
“poor”, “fair”, “good”, “very good”, “excellent”. All scores
are linearly transformed on a 0 to 100 scale, with a
higher score reflecting a higher level of satisfaction.
The EORTC QLQ-C30 (version 3.0) is a 30-item self-
assessment questionnaires of QoL comprising 5 func-
tional scales (physical, role, emotional, cognitive, social),
9 symptom scales (fatigue, nausea or vomiting, pain,
dyspnea, insomnia, constipation, diarrhea, financial diffi-
culties) and finally, a global health scale.
The assessment of socio-demographic and disease-related
variables has been described in detail elsewhere [21].
Statistical methods
Characteristics of patients who completed the whole
questionnaire were compared to those who returned
questionnaires with missing data using Fisher’s exact
test, or the Chi-square test for categorical data, and the
Student t test for continuous data. If missing data in
questionnaires were identified as MNAR (missing not atrandom), each scale score was estimated with a multiple
imputation by the Markov Chain Monte Carlo method
(MI procedure).
To illustrate the clinical significance of the variation in
QoL, the within-group changes in EORTC QLQ-C30
scores (follow-up scores minus baseline) were categorized
in three classes, improvement, no change, or deterior-
ation, with a minimal difference, of either 5 points or 10
points, defining a little change or a moderate change re-
spectively [26]. This method was used for each EORTC
QLQ-C30 scale. Furthermore, because we hypothesized
that the variation in QoL would not be linear (worse at
the end of treatment compared to baseline, due to treat-
ment side effects, and probably better three months after,
if recovery had been possible), two models were built
using the QoL score changes: i.e. between the beginning
and the end of treatment on the one hand, and between
the beginning of treatment and three months after the
end of treatment on the other hand.
Significant categorical variables (primary localization,
type of treatment, age, sex, marital status, leisure activ-
ities, home-hospital distance and monthly income) and
continuous variables (EORTC QLQ-C30 scores at base-
line and changes in global health, emotional functioning,
social functioning, sleep, fatigue and pain) identified as
possible predictors in previous analysis at baseline [21],
were introduced into the multivariate models. However,
primary localization (breast, prostate, head and neck, rec-
tum, or lung) and type of treatment received (radiotherapy
and/or chemotherapy) were included into two separate
models due to the strong colinearity between these two
variables. A general linear model (analysis of variance),
taking into account repeated measures for a same patient,
was used for each scale score of the OUT-PATSAT35
questionnaire at the three assessment time points. Inter-
action with time for each variable was also investigated.
We distinguished two levels of analysis of satisfaction
scores: first, a longitudinal analysis evaluating within-
group changes between two assessment time points (fol-
low-up scores at the end of treatment minus baseline
and follow-up scores at three months after the end of
treatment minus baseline), and secondly a cross-
sectional analysis evaluating between-group changes at
the end of treatment and three months later.
The significance level for multivariate analysis was set
at α = 0.005 (according to Bonferroni correction for mul-
tiple testing). All tests were two-sided.
For the interpretation of the satisfaction scores, we
considered the minimal difference defined as clinically
meaningful by Osoba et al., namely a mean change of at
least 5 points [26].
Statistical analysis was performed using Statistical
Analysis Software (version 9.1, SAS Institute, Cary, NC,
USA).
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Patient characteristics at baseline
733 patients met the eligibility criteria and were invited to
participate in the study: 42 patients (5.7%) declined, and
the remaining 691 (94.3%) patients were included. Baseline
characteristics of the study population are summarized in
Table 1. Median age was 65 years (range 29–88), with a
balanced proportion of men and women. All patients were
treated with curative intent except for 5 patients who had




Center Teaching hospital 382 (55.3)
Local hospital 309 (44.7)
Sex Male 356 (51.5)
Female 335 (48.5)





Marital status Single or separated 136 (19.9)
Living with partner, or family 548 (80.1)
Education level Primary 317 (47.1)
Secondary 167 (24.8)
High school diploma or
higher
189 (28.1)
Employment status Employed 175 (25.6)




MW- 1499 218 (34.8)
1500 -2999 247 (39.4)
≥ 3000 92 (14.7)
Localization treated Prostate RT 128 (18.5)
Surgery + RT 82 (11.9)
Head and neck Surgery + RT 22 (3.2)
RT+/−CT 71 (10.3)
Breast Surgery + RT 205 (29.7)
Surgery + CT + RT 100 (14.5)
CT 5 (0.7)
Rectum RT + CT + surgery 23 (3.3)
Lung CT + RT 55 (8)
Chemotherapy Yes 221 (32)
Radiotherapy Yes 585 (84.7)
Min =minimum; max =maximum; MW =minimum wage;
RT = radiotherapy, CT = chemotherapy.on the hypothesis that these patients could behave differ-
ently from the rest of the patients, we excluded them from
subsequent analyses. Most cancer localizations treated
were breast (44%) and prostate cancer (31%).
Missing data on the OUT-PATSAT35 questionnaires
Missing data in questionnaires were identified as
MNAR, so each scale score was estimated with a mul-
tiple imputation by age and treatment type (radiotherapy
vs. chemotherapy).
Six patients were non-responders at baseline and were
excluded from the analysis. 49 patients responded at
baseline only, and 79 patients responded at the begin-
ning and at the end of treatment but not at 3 months
after treatment. Comparison of characteristics between
these 128 patients lost to follow-up (19% of the all those
included) and the 561 patients who answered at all 3 as-
sessment time points revealed a lower level of QoL at
baseline and a higher frequency of lung or head and
neck cancers.
Variation of satisfaction and QoL scores
Mean satisfaction scores by scale did not change much
over time whereas mean EORTC QLQ-C30 scores dete-
riorated between baseline and the end of treatment, then
improved three months after treatment (Figure 1).
Multivariate analysis of satisfaction scores
The longitudinal analysis showed significant relation-
ships between the within-group changes in global health
score (adjusted for global health score at baseline), and
the within-group changes in satisfaction scores. During
the treatment period, an improvement in the global
health score, of a minimum of either 5 or 10 points,
was significantly related to an increase in overall satis-
faction score (mean score differences of 9 and 12 points
respectively in the model with radiotherapy, p ≤ 0.0002,
Additional file 1).
Between the beginning of treatment and three months
after the end of treatment, an improvement in global
health, with a minimal difference of either 5 or 10
points, was again significantly related to an increase in
overall satisfaction score (mean score difference of 7
points, in both cases, in the model with radiotherapy,
p ≤ 0.004), whereas a deterioration in global health, with
a minimal difference of either 5 or 10 points, was signifi-
cantly linked to a decrease in satisfaction with doctors’
technical skills, interpersonal skills, and provision of infor-
mation (mean score differences ranged from 8 to 16
points in the model with primary localization, p ≤ 0.0001,
Additional file 1).
By cross-sectional analysis evaluating between-group
changes in satisfaction scores, at the end of the treat-






























































Figure 1 Longitudinal evolution of OUT-PATSAT35 and QLQC30 scores at the 3 assessment time points*. *Only the most representative
dimensions are shown. Abbreviations: SATGEN = overall satisfaction, SATDTS doctor technical skills, SATDIS = doctor interpersonal skills, SATDIP =
information provided by doctor, SATDAV = doctor availability, SF = social functioning, RF = role functioning, QL = global health, FA = fatigue,
PA = pain. T1: start of treatment, T2 : end of treatment, T3 : three months after the end of treatment.
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on most scales, as compared to those who reported an
improvement in global health (mean score differences
ranged from 8 to 20 points). The greatest differences in
satisfaction scores were observed in overall satisfaction, in
satisfaction with doctors’ technical skills, interpersonal
skills, provision of information and nurses or radiation
therapists’ provision of information and availability, and
after adjustment for a minimal change in global health
of 10 points compared to a minimal change of 5 points
(p ≤ 0.001, Additional file 2).
Three months after the end of treatment, patients who
experienced a decrease in global health scores since the
start of treatment reported less satisfaction mainly withdoctors’ technical skills, interpersonal skills, provision of
information and availability (mean score differences
ranged from 10 to 19 points). This effect was again more
significant after adjustment for a minimal change in glo-
bal health of 10 points compared to a minimal change of
5 points (p ≤ 0.002, Additional file 2).
As reported in previous work [21], perceived global
health at the beginning of treatment remained largely
and significantly associated with all satisfaction scores,
not only at the start of treatment but also at the subse-
quent time points (p < 0.0001, data not shown)
Younger age (≤55 years) was significantly linked to dis-
satisfaction with doctors’ availability and the hospital en-
vironment at the three assessment time points (p ≤ 0.002):
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and those >75 years old, were ≥10 points at the end after
treatment and three months later (Figure 2).
Radiotherapy (as opposed to chemotherapy) was sig-
nificantly associated with lower satisfaction with doctors’
technical skills, interpersonal skills, doctors’ and nurses’
provision of information and waiting time (p ≤ 0.005).
The score difference was larger at the end of treatment
than three months later (for instance, mean score differ-
ences of 10 and 5 points respectively in satisfaction with
















































Figure 2 Influence of age on satisfaction scores at the 3 assessment t
marital status, centre, level of global health at inclusion and minimal differe
SATDAV = doctors’ availability, SATPE = physical environment.Patients treated for head and neck cancer were less
satisfied with doctors’ provision of information, and hos-
pital environment as compared to those treated for pros-
tate cancer at the three assessment time points: for
instance, mean score differences ranged from 8 to 11
points in satisfaction with doctors’ provision of informa-
tion (p = 0.002, Figure 4).
Discussion
Initial self-reported global health and its variation across
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Figure 3 Influence of type of treatment on satisfaction scores at the 3 assessment time points$. $Mean satisfaction scores adjusted for
radiotherapy, age, marital status, centre, level of global health at inclusion and minimal difference scores of 10 points for global health changes.
Abbreviations: SATDIP = doctors’ information provision, SATNIP = nurses’ information provision.
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chemotherapy or radiation therapy. The longitudinal
analysis studying within-group changes in satisfaction
scores, showed a different effect of changes in global
health score, depending on the satisfaction scale consid-
ered: an improvement in global health was significantly
related to an increase in the overall satisfaction score,
whereas a deterioration in global health was linked to a
decrease in satisfaction with doctors, this latter relation-
ship becoming significant during the period between the
beginning of treatment and three months after the end
of treatment. The cross-sectional analysis (evaluating
between-group changes in satisfaction scores) showed
lower satisfaction scores in patients who experienced adeterioration in their global health on most scales of
OUT-PATSAT35 at the end of treatment, and mainly on
the scales reporting satisfaction with doctors three
months after the end of treatment.
In the longitudinal analysis of satisfaction scores, we
observed discrepancies in the results between the overall
satisfaction scale and the doctors’ scales. These findings
may be explained by the limited score variability due to
the ceiling effect that was frequently observed on the
overall satisfaction scale, where a large proportion of pa-
tients scored the maximum [27]. In other words, high
satisfaction ratings do not necessarily mean that the
patients had had a positive experience of healthcare.
Conversely, dissatisfaction rates may better reflect a







































































Figure 4 Influence of primary localization on satisfaction scores at the 3 assessment time points$. $Mean satisfaction scores adjusted for
primary localization, age, marital status, centre, level of global health at inclusion and minimal difference scores of 10 points for global health
changes. Abbreviations: SATDIP = doctors’ information provision, SATPE = physical environment.
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[28]. In our study, the deterioration of patient QoL dur-
ing treatment, probably linked to acute toxicities, may
have increased anxiety related to the cancer issue or the
potential complications of the treatment. Thus, it may
have generated greater patient expectations about med-
ical information, making them more difficult to satisfy.
In a large outpatient cohort of more than 4600 cancer
patients, Feyer et al. [29] showed that fatigue and the
number of treatment side effects self- reported by the
patient had a negative impact on the patients’ assess-
ment of cancer care: more than 30% of these patients
were not satisfied with the information they received
about adverse events and their handling. Therefore, the
question remains whether a reduction in these side-effects would result firstly in better patient QoL, and sub-
sequently, in improved satisfaction with care. Future re-
search should include a thorough evaluation of cancer-
related adverse events using a validated instrument that
systematically assess both the presence and the severity of
symptoms.
Furthermore, it is noteworthy that the greatest decrease
in satisfaction scores was observed in the scales evaluating
doctors compared to nurses or radiation therapists, and
especially when considering the assessment at three
months after the end of treatment. It can thus be hypothe-
sized that during this period, patients have had greater ex-
pectations with doctors than with other caregivers,
essentially linked to a need of information about the ef-
fectiveness of treatment and the cancer prognosis.
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apy, was significantly linked to lower satisfaction scores
in terms of information provided and waiting times.
These results should be interpreted with caution, how-
ever, because the few patients receiving chemotherapy
were those treated for breast cancer, and in these pa-
tients, the end of chemotherapy was not the end of the
overall treatment as they had radiotherapy afterwards.
Thus, the expectations of these patients vis-à-vis their
caregivers may not have been as high as those in whom
the end of radiotherapy was also the end of their
treatment.
Stiegelis et al. analyzed the psychological functioning
of patients treated with radiotherapy through 45 studies
[30] and found no significant differences in feelings of
anxiety, depressive symptoms or psychological distress
between patients treated with radiotherapy and those
treated with other treatment modalities. Furthermore,
this body of work suggests a strong relationship between
the amount of physical side-effects of treatment and psy-
chological dysfunction, which tends to be higher in the
last week of radiotherapy when adverse events reach
their peak. During the months following the completion
of treatment, psychological dysfunction may also con-
tinue. A possible reason for this finding is that cancer
patients may enter a period in which the persistence of
treatment side effects associated with the uncertainty
about the effectiveness of radiotherapy in controlling the
cancer, on the one hand, and the loss of the support net-
work (i.e. relations with medical staff ), on the other hand,
combine to create a difficult context that can promote
psychological distress, and may be a cause of dissatisfac-
tion with the information supplied by care providers [31].
Patients suffering from head and neck cancer, who
were the least satisfied with the information provided by
doctors and the hospital environment, are probably
those who experience the most symptoms and physical
side-effects, either associated with their illness or the ra-
diation therapy, involving impairments in functional do-
mains as eating, speaking or breathing. Moreover, the
treatment toxicities are often intense, last for several
months, even persisting as long-term sequelae. An
English study assessing satisfaction with the provided
information to 82 head and neck cancer patients, in
which 73% received radiotherapy, revealed a need for
more information about the impact of treatment and
especially the long-term effects [32]. Regarding satis-
faction between different primary cancers, in a national
survey of cancer patients’ satisfaction with care in
55,674 English patients, Sherlaw-Johnson et al. found
that hospital satisfaction varied by cancer type (for
breast, colorectal, lung and prostate cancer patients):
breast and lung cancer patients were more satisfied
than patients with colorectal cancer, while prostatecancer patients tended to be least satisfied [6]. Con-
versely, in a Canadian study including 2,790 patients,
Sandoval et al. found that prostate cancer patients re-
ported a higher level of overall satisfaction compared
to other primary localizations, including head and
neck, brain, breast, gynaecological, lung and digestive
cancers [7].
Consistent with a number of previous studies [6,8,15],
we show that younger age was linked to less satisfaction
with some aspects of care. It has been suggested that
older people trust their doctor more and have more
modest expectations [27].
The overall response rate in our study population was
in line with the methodological minimum requirement
of 80%, since 99% of patients completed the OUT-
PATSAT35 questionnaires at inclusion, 88% at the second
assessment and 81% at the third time point, confirming
the acceptability of the OUT-PATSAT35 questionnaire in
a large outpatient sample. In satisfaction surveys, response
rates have been shown to range from 66 to 77%, depend-
ing on the procedure for data collection [33].
Patients with a lower QoL at baseline and treated for
lung or head and neck cancers were less likely to re-
spond to the follow-up assessments. Despite this poten-
tial bias, in our longitudinal analysis, we identified a
significant relationship between a low global health score
at baseline and low satisfaction scores in the subsequent
assessments. It can thus be hypothesized that this effect
of initial global health may have been underestimated.
Another potential bias related to the study procedures
has to be underscored. Since the questionnaires at the
second and the third time points were fulfilled at home,
patients’ responses could have been influenced by their
proxies. Sandoval et al. shown that scores evaluating
overall perception of the quality of care were signifi-
cantly lower in cases where someone other than the pa-
tient completed the survey [7].
Although a number of variables were found to be sig-
nificantly associated with satisfaction scores, all the com-
bined covariates explained only 10 to 12% of the
observed variation in satisfaction with care in our sam-
ple. Having the disease under control as an outcome of
care was not introduced into the model, since this criter-
ion was considered not to be relevant in the study con-
text. Most patients underwent surgery and had no
residual disease, and for patients who did not undergo
surgery, a three month delay was insufficient to ascertain
whether the cancer was under control. In a sample of
the World Health Survey for 2003 including 16,384 pa-
tients in 21 European Union countries, factors such as
age, income, education, immunization coverage, and
self-reported health status were significantly associated
with satisfaction with the healthcare system. However,
these predictors only explained 7.5% of the variation in
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with care were added to the model, the proportion of
variation in satisfaction scores explained only increased
to 17.5%. The authors suggest that some of the remaining
variation in satisfaction with the healthcare system could
be explained by broader societal factors, like the media’s
influence on patients’ perception of the health system, but
such factors are unfortunately difficult to capture with
questionnaires [15].
Despite this gap in our understanding of the factors
related to the patient’s determination of their satisfaction
with care, one of the main motivations for measuring
patient satisfaction is to help recognize and thus resolve
potential patient dissatisfaction problems. From a man-
agement perspective, it may contribute to emphasising
priorities in terms of investments for health care organi-
zations: for example, in our study, waiting times (for
obtaining an appointment or how easy it was to reach a
caregiver by phone) and the physical environment of the
hospital (access, comfort) were the domains in which pa-
tients reported lowest levels of satisfaction. Thus, these
findings could support a request for more human re-
sources on the one hand, and a project to extend park-
ing capacity on the other hand. From a health care
provider’s perspective, satisfaction surveys aim to iden-
tify patients’ needs and expectations. In our study, dis-
satisfaction was reported on the scale relating to the
doctors’ provision of information, especially in patients
younger than 55 years and those treated for head and
neck cancer. As a result, concerted efforts to deliver ad-
equate information adapted to these patients’ groups had
to be made. Effective doctor-patient communication has
been associated with improved psychological functioning
of the patient, adherence to treatment, higher QoL and
greater satisfaction with care [34-36]. However, with
cancer patients, doctors are often confronted with diffi-
cult issues for which they are unprepared, such as com-
municating bad news, preparing for adverse procedures,
exploring treatment options, enrolling the patient in clin-
ical trials or discussing prognosis. Consequently, various
initiatives to improve communication between doctors
and cancer patients have been developed, focusing either
on patients (standardised information provided on a video
or in a medical information package [37,38]) or on doctors
(training in communication skills [39,40]).
Our results showed that patient’s global health at the
beginning of treatment was the major determinant of
satisfaction with care, during and after treatment. It can
be hypothesized that identifying these patients with poor
QoL as early as possible in the care pathway, and pro-
viding them with comprehensive supportive care should
improve their perception of the subsequent delivery of
the cancer treatment. It has been shown that the meas-
urement of individual patient health-related QoL can beused in clinical practice to detect physical or psychological
problems providing useful information to caregivers and
thus, facilitating doctor-patient communication [41,42].
Furthermore, previous work by Velikova et al. indicates
that routine repeated QoL measurements with feedback
of results to doctors leads to an increased discussion of
health-related QoL issues, resulting in clinically meaning-
ful improvement in patient well-being [43]. In addition,
according to a National Institutes of Health expert panel
report, clinicians should routinely use brief assessment
tools to ask patients systematically about symptoms and
side-effects, with the aim of initiating appropriate treat-
ment as soon as possible [44].
Lastly, patient satisfaction with care reflects the extent
to which the patients’ needs, desires or preferences are
met. In order to satisfy the patients’ expectations, health-
care providers should adapt their behavior and commu-
nication style to each individual, and thus move towards
patient-centered delivery of care.
Conclusions
Our study brought to light the major impact of self-
reported overall health status at the beginning of the
cancer treatment, as well as its variations over time, on
most domains of satisfaction with care. To the best of
our knowledge, this is the first longitudinal study to re-
port on the responsiveness of a satisfaction question-
naire to QoL changes over time.
The strong relationship between health-related overall
QoL and patient satisfaction with care underscores the
necessity of evaluating these two subjective measures
when comparing different treatments, patterns of care,
or health care systems at a given time point, but also
when assessing variations in patient satisfaction over
time with intent to measure, for instance, the health sys-
tem “responsiveness” in improving the quality of care.
From the healthcare professional’s point of view, it
might be expected that early initiatives aimed at improv-
ing the delivery of care in patients with poor health sta-
tus would lead to a better perception of the quality of
care received and thus a higher satisfaction with care.
Challenges in the future should address the appropri-
ate interpretation, report and use patient satisfaction
survey data to efficiently improve quality of care.
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